— Know what they know.
Not Investment Advice
Also trades as: PA8.DE (XETRA) · $vol 0M · PA8.F (FSX) · $vol 0M · 0NF3.L (LSE) · $vol 0M

PAIOF OTC

Paion AG
1W: +0.0% 1M: +0.0% 3M: +600.0% YTD: +600.0% 1Y: +600.0% 3Y: -99.0% 5Y: -99.8%
$0.07
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 46 · $526847 mcap · 6M float · 0.0001% daily turnover

Income Trends

Revenue
$33M +366.4% ▲
5Y CAGR: +41.7%
Gross Profit
$31M +672.4% ▲
5Y CAGR: +40.0%
Operating Income
$2M +106.8% ▲
Net Income
-$579K +97.3% ▲
EPS (Diluted)
$-0.08 +97.4% ▲
EBITDA
$4M +122.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$3M$8M$20M$7M$33M
YoY Growth-52.4%+189.2%+145.7%-63.7%+366.4%
Cost of Revenue$0$0$0$3M$2M
Gross Profit$3M$8M$20M$4M$31M
Gross Margin100.0%100.0%100.0%56.8%94.1%
R&D Expenses$12M$13M$10M$5M$6M
SG&A Expenses$3M$5M$8M$20M$21M
Operating Expenses$16M$17M$18M$26M$30M
Operating Income-$12M-$9M$2M-$22M$2M
Operating Margin-450.3%-116.6%8.1%-309.8%4.5%
Interest Expense$0$123K$163K$2M$3M
Income Before Tax-$12M-$9M$1M-$23M-$201K
Tax Expense-$3M-$2M-$792K-$796K$378K
Net Income-$10M-$7M$2M-$22M-$579K
Net Margin-359.3%-87.7%11.3%-305.6%-1.7%
EPS (Diluted)$-1.56$-1.08$0.33$-3.10$-0.08
EBITDA-$13M-$9M$2M-$19M$4M
Shares Outstanding6M7M7M7M7M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms